Page last updated: 2024-09-03

mk 0663 and 2-acetylaminofluorene

mk 0663 has been researched along with 2-acetylaminofluorene in 1 studies

Compound Research Comparison

Studies
(mk 0663)
Trials
(mk 0663)
Recent Studies (post-2010)
(mk 0663)
Studies
(2-acetylaminofluorene)
Trials
(2-acetylaminofluorene)
Recent Studies (post-2010) (2-acetylaminofluorene)
5491732652,352097

Protein Interaction Comparison

ProteinTaxonomymk 0663 (IC50)2-acetylaminofluorene (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)2.143
Cytochrome P450 1A2Homo sapiens (human)0.016
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)8.595
Amine oxidase [flavin-containing] AHomo sapiens (human)0.059
Sodium-dependent noradrenaline transporter Homo sapiens (human)8.595
5-hydroxytryptamine receptor 2CHomo sapiens (human)2.143
Sodium-dependent serotonin transporterHomo sapiens (human)6.053
5-hydroxytryptamine receptor 2BHomo sapiens (human)3.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abo-Youssef, A; Ahmed, O; Ali, G; Hersi, F; Mohamed, W; Omar, H1

Other Studies

1 other study(ies) available for mk 0663 and 2-acetylaminofluorene

ArticleYear
The Protective Role of Etoricoxib Against Diethylnitrosamine/2-acetylaminofluorene- Induced Hepatocarcinogenesis in Wistar Rats: The Impact of NF-κB/COX-2/PGE2 Signaling.
    Current molecular pharmacology, 2022, Volume: 15, Issue:1

    Topics: 2-Acetylaminofluorene; Animals; Carcinoma, Hepatocellular; Cyclooxygenase 2; Diethylnitrosamine; Dinoprostone; Etoricoxib; Female; Humans; Liver Neoplasms; Male; NF-kappa B; Rats; Rats, Wistar

2022